News
PRQR
--
0.00%
--
Reflecting on ProQR Therapeutics' (NASDAQ:PRQR) Share Price Returns Over The Last Five Years
We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly...
Simply Wall St. · 1d ago
ProQR to Participate in Upcoming Investor Conferences
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of transformative RNA medicines for inherited retinal diseases (IRDs), today announced that Company management
GlobeNewswire · 09/03 12:00
Jounce Therapeutics rallies on license deal with Gilead, Tracon Pharma follows, I-Mab, Kindred Biosciences among major losers
Gainers: Jounce Therapeutics (JNCE) +42%, TRACON Pharmaceuticals (TCON) +13.8%, Nano-X Imaging (NNOX) +13.6%, Athenex (ATNX) +11.5%, Surface Oncology (SURF) +8%.Losers: I-Mab (IMAB) -14.5%, Kindred Biosciences (KIN) -13.7%, ProQR Therapeutics (PRQR) -13%, Vaxart (VXRT) -12.9%, ADiTx Therapeutics (ADTX) -12.2%.
Seekingalpha · 09/01 14:57
ProQR Therapeutics: Bringing A New Cure To The Market
Covid-19 is delaying ProQR’s pivotal trial, leading to share price fall.There is uncertainty around when the trial will be finished, which can potentially delay the revenue into 2023.The company is sufficiently funded into H2 2022 and their drug pipeline looks positive.
Seekingalpha · 08/31 18:30
ProQR reports Q2 results
ProQR (NASDAQ:PRQR): Q2 GAAP EPS of -€0.08. Other income of €8.67M (+1448.2% Y/Y). Cash and equivalents of €87.1M. Press Release
seekingalpha · 08/07 02:25
ProQR Announces Second Quarter 2020 Operating and Financial Results
* Positive preliminary data from InSight extension study of sepofarsen for LCA10 reported – consistent with benefit seen in Phase 1/2 and building confidence in Phase 2/3 Illuminate trial; * Strategic convertible debt financing extends runway into 2023 if ful
GlobeNewswire · 08/06 20:30
ProQR Strengthens Scientific Advisory Board with Leaders in Inherited Retinal Disease and RNA Therapy
LEIDEN, Netherlands & CAMBRIDGE, Mass., July 21, 2020 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative.
GlobeNewswire · 07/21 11:00
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14)
Benzinga · 07/15 11:30
ProQR secures debt financing of $30M
ProQR Therapeutics (NASDAQ:PRQR) rises ~6% AH, after it announces a $30M convertible debt financing agreement with Pontifax. The company says that the capi
seekingalpha · 07/15 01:48
ProQR Announces $30M Strategic Convertible Debt Financing Agreement With Pontifax Ventures
Benzinga · 07/14 20:33
ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
Extends ProQR’s cash runway into 2023ProQR can trigger conversion of the debt to equity at $7.88 per share, under certain conditions LEIDEN, Netherlands & CAMBRIDGE,.
GlobeNewswire · 07/14 20:30
ProQR To Host 'Expert Perspectives' Call On LCA10 And Sepofarsen Jul. 20
Call on July 20 will include a snapshot from the ongoing InSight open-label extension study of sepofarsen, including preliminary second eye treatment data LEIDEN, Netherlands & CAMBRIDGE, Mass., July 13, 2020 (GLOBE
Benzinga · 07/13 20:33
News Flash: Analysts Just Made A Stunning Upgrade To Their ProQR Therapeutics N.V. (NASDAQ:PRQR) Forecasts
Simply Wall St. · 06/29 13:32
The Zacks Analyst Blog Highlights: Smith & Wesson, Zscaler, Sportsman's Warehouse, ProQR and Ooma
Zacks · 06/23 16:32
Hedge Funds Souring On ProQR Therapeutics NV (PRQR)
Insider Monkey · 06/22 19:42
5 Must-Buy Low-Beta Stocks Flying High in a Volatile Market
Zacks · 06/22 12:10
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke And Ultragenyx
Biotech stocks came under pressure along with the broader market in the week ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-board sell-off in the global markets.
Benzinga · 06/14 14:20
ProQR Announces Expert Perspectives Conference Call Series
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 12, 2020 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative.
GlobeNewswire · 06/12 11:00
ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Data Through the Association for Research in Vision and Ophthalmology (ARVO)
LEIDEN, Netherlands & CAMBRIDGE, Mass., June 08, 2020 -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative.
GlobeNewswire · 06/08 11:00
How ProQR (PRQR) Stock Stands Out in a Strong Industry
ProQR (PRQR) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks · 05/29 12:55